Skip to main content
Loading...
Menu top
Help
User account menu
Log in
Main navigation
Programme
Posters
Industry Symposia
Membership
Mobile Application
Menu
Login
Close
Main navigation mobile
Programme
Posters
Industry Symposia
Membership
Mobile Application
Back
123 résultats
Grid
List
Head and neck cancers with synchronous primary cancers in Ireland
Selected inoperable oral cavity cancers may be salvaged using definitive radiotherapy (RT) and chemo-radiotherapy (CRT): A single center experience.
Automated analysis of elective neck radiation therapy patterns in patients with head and neck cancer
Onco-biota as prognostic factors in Head and Neck Squamous Cell Carcinoma
A five-year experience of intensity modulated radiotherapy in nasopharyngeal carcinomas in Tunisia
Pembrolizumab plus platinum and taxanes as first-line and as neoadjuvant/induction therapies in PF-unfit patients with PDL1-positive squamous cell carcinoma of the head and neck
Prognostic and Survival analysis of patients with locally advanced nasopharyngeal carcinoma with optic pathways involvement.
Real world data on Low-Dose Nivolumab with Triple Metronomic Chemotherapy: Retrospective analysis of 50 consecutive patients from LMICs
Oncological outcomes and pattern of care in sinonasal malignancy treated with a multimodality approach.
“A Retrospective study comparing sequential boost versus integrated boost using volumetric Arc Radiotherapy along with concurrent chemotherapy for Locally Advanced Head and Neck Cancer”.
Differentiated Thyroid Cancer with Synchronous second Primary Cancer : Retrospective study from a cancer institute in India
Point Of Care Ultrasound (POCUS) in Tracheostomy in Head and Neck Cancer : A Prospective Study.
Efficacy of nivolumab versus pembrolizumab in rmHNSCC. A prospective national multicenter study.
Classifying of patterns of locoregional failure using radiotherapy dose fields in head-and-neck cancer: Cambridge VoxTox Study
Survival Analysis of Localized Subglottic Squamous Cell Carcinoma: Therapeutic Options and Outcomes
Efficacy and Safety of Salvage Chemotherapy After Progression to Anti-PD(L)1 Agents in Patients with Recurrent/Metastatic Head and Neck Cancer
Can machine-learning model predict overall survival in head and neck cancer patients?.
Impact of Therapeutic Options on Survival Rates in Localized Supraglottic Squamous Cell Carcinoma
The Impact of Joint Radiologist Input in Head and Neck Radiotherapy Peer Review on MDT's TNM Classification and Outcome
Prevalence of depression among patients with Head and Neck cancer
Pagination
Previous page
‹‹
Page 4
Next page
››